Press Release Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update Aug 6
Press Release Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease Aug 3